Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines

Molecular Pharmaceutics

Volumn 9, Issue 1, 2012, Pages 81-90

  Chua, Brendon Y ^a   Al Kobaisi, Mohammad ^b   Zeng, Weiguang ^a   Mainwaring, David ^b   Jackson, David C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

chitosan; immunocontraception; microparticles; nanoparticles; vaccine delivery

Indexed keywords

CHITOSAN; CONTRACEPTIVE VACCINE; GONADORELIN; IMPROVAC; NANOPARTICLE; UNCLASSIFIED DRUG;

ACETYLATION; AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CHLOROACETYLATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETIC ACIDS; ACETYLATION; ANHYDRIDES; ANIMALS; CELLS, CULTURED; CHITOSAN; DENDRITIC CELLS; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; GONADOTROPIN-RELEASING HORMONE; HALOGENATION; IMMUNITY, ACTIVE; LYMPH NODES; MICE; MICE, INBRED BALB C; MICROSPHERES; NANOPARTICLES; PARTICLE SIZE; PEPTIDE FRAGMENTS; SURFACE PROPERTIES; TISSUE DISTRIBUTION; VACCINES, CONTRACEPTIVE;

EID: 84855418341     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200264m     Document Type: Article

References (42)

1. Arca, H. C.; Gunbeyaz, M.; Senel, S. Chitosan-based systems for the delivery of vaccine antigens Expert Rev. Vaccines 2009, 8, 937-953
2. Slutter, B.; Bal, S. M.; Que, I.; Kaijzel, E.; Lowik, C.; Bouwstra, J.; Jiskoot, W. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles? Mol. Pharmaceutics 2010, 7, 2207-2215
3. Slutter, B.; Soema, P. C.; Ding, Z.; Verheul, R.; Hennink, W.; Jiskoot, W. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen J. Controlled Release 2010, 143, 207-214
4. Zaharoff, D. A.; Rogers, C. J.; Hance, K. W.; Schlom, J.; Greiner, J. W. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination Vaccine 2007, 25, 2085-2094 (Pubitemid 46227669)
5. Khatri, K.; Goyal, A. K.; Gupta, P. N.; Mishra, N.; Vyas, S. P. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B Int. J. Pharm. 2008, 354, 235-241
6. Zhou, X.; Zhang, X.; Yu, X.; Zha, X.; Fu, Q.; Liu, B.; Wang, X.; Chen, Y.; Shan, Y.; Jin, Y.; Wu, Y.; Liu, J.; Kong, W.; Shen, J. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine Biomaterials 2008, 29, 111-117 (Pubitemid 47599656)
7. Amidi, M.; Romeijn, S. G.; Verhoef, J. C.; Junginger, H. E.; Bungener, L.; Huckriede, A.; Crommelin, D. J.; Jiskoot, W. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model Vaccine 2007, 25, 144-153 (Pubitemid 44855251)
8. Prego, C.; Paolicelli, P.; Diaz, B.; Vicente, S.; Sanchez, A.; Gonzalez-Fernandez, A.; Alonso, M. J. Chitosan-based nanoparticles for improving immunization against hepatitis B infection. Vaccine 28, 2607-2614.
9. Sui, Z.; Chen, Q.; Fang, F.; Zheng, M.; Chen, Z. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant Vaccine 2010, 28, 7690-7698
10. Amidi, M.; Pellikaan, H. C.; Hirschberg, H.; de Boer, A. H.; Crommelin, D. J.; Hennink, W. E.; Kersten, G.; Jiskoot, W. Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs Vaccine 2007, 25, 6818-6829 (Pubitemid 47332722)
11. Kang, M. L.; Kang, S. G.; Jiang, H. L.; Shin, S. W.; Lee, D. Y.; Ahn, J. M.; Rayamahji, N.; Park, I. K.; Shin, S. J.; Cho, C. S.; Yoo, H. S. In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT Eur. J. Pharm. Biopharm. 2006, 63, 215-220 (Pubitemid 43776213)
12. Sayin, B.; Somavarapu, S.; Li, X. W.; Thanou, M.; Sesardic, D.; Alpar, H. O.; Senel, S. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery Int. J. Pharm. 2008, 363, 139-148
13. Florindo, H. F.; Pandit, S.; Goncalves, L. M.; Videira, M.; Alpar, O.; Almeida, A. J. Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres Biomaterials 2009, 30, 5161-5169
14. Xie, Y.; Zhou, N. J.; Gong, Y. F.; Zhou, X. J.; Chen, J.; Hu, S. J.; Lu, N. H.; Hou, X. H. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection World J. Gastroenterol. 2007, 13, 1547-1553 (Pubitemid 46672663)
15. Fifis, T.; Gamvrellis, A.; Crimeen-Irwin, B.; Pietersz, G. A.; Li, J.; Mottram, P. L.; McKenzie, I. F.; Plebanski, M. Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors J. Immunol. 2004, 173, 3148-3154 (Pubitemid 39142021)
16. Mottram, P. L.; Leong, D.; Crimeen-Irwin, B.; Gloster, S.; Xiang, S. D.; Meanger, J.; Ghildyal, R.; Vardaxis, N.; Plebanski, M. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus Mol. Pharmaceutics 2007, 4, 73-84
17. Manolova, V.; Flace, A.; Bauer, M.; Schwarz, K.; Saudan, P.; Bachmann, M. F. Nanoparticles target distinct dendritic cell populations according to their size Eur. J. Immunol. 2008, 38, 1404-1413
18. Reddy, S. T.; Rehor, A.; Schmoekel, H. G.; Hubbell, J. A.; Swartz, M. A. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles J. Controlled Release 2006, 112, 26-34
19. Chen, H. C.; Sun, B.; Tran, K. K.; Shen, H. Effects of particle size on toll-like receptor 9-mediated cytokine profiles Biomaterials 2011, 32, 1731-1737
20. Cohen, J. A.; Beaudette, T. T.; Tseng, W. W.; Bachelder, E. M.; Mende, I.; Engleman, E. G.; Frechet, J. M. T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size Bioconjugate Chem. 2009, 20, 111-119
21. Tran, K. K.; Shen, H. The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells Biomaterials 2009, 30, 1356-1362
22. Waters, K. M.; Masiello, L. M.; Zangar, R. C.; Tarasevich, B. J.; Karin, N. J.; Quesenberry, R. D.; Bandyopadhyay, S.; Teeguarden, J. G.; Pounds, J. G.; Thrall, B. D. Macrophage responses to silica nanoparticles are highly conserved across particle sizes Toxicol. Sci. 2009, 107, 553-569
23. Delves, P. J.; Lund, T.; Roitt, I. M. Antifertility vaccines Trends Immunol. 2002, 23, 213-219 (Pubitemid 34260938)
24. Chua, B. Y.; Zeng, W.; Lau, Y. F.; Jackson, D. C. Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups Vaccine 2007, 25, 92-101 (Pubitemid 44855240)
25. Jung, M. J.; Moon, Y. C.; Cho, I. H.; Yeh, J. Y.; Kim, S. E.; Chang, W. S.; Park, S. Y.; Song, C. S.; Kim, H. Y.; Park, K. K.; McOrist, S.; Choi, I. S.; Lee, J. B. Induction of castration by immunization of male dogs with recombinant gonadotropin-releasing hormone (GnRH)-canine distemper virus (CDV) T helper cell epitope p35 J. Vet. Sci. 2005, 6, 21-24 (Pubitemid 40515636)
26. Khan, M. A.; Ferro, V. A.; Koyama, S.; Kinugasa, Y.; Song, M.; Ogita, K.; Tsutsui, T.; Murata, Y.; Kimura, T. Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo Vaccine 2007, 25, 3544-3553 (Pubitemid 46575103)
27. Talwar, G. P.; Vyas, H. K.; Purswani, S.; Gupta, J. C. Gonadotropin-releasing hormone/human chorionic gonadotropin beta based recombinant antibodies and vaccines J. Reprod. Immunol. 2009, 83, 158-163
28. Oonk, H. B.; Turkstra, J. A.; Schaaper, W. M.; Erkens, J. H.; Schuitemaker-de Weerd, M. H.; van Nes, A.; Verheijden, J. H.; Meloen, R. H. New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRH Vaccine 1998, 16, 1074-1082 (Pubitemid 28307873)
29. Gonzalez, G.; Lage, A. Cancer vaccines for hormone/growth factor immune deprivation: a feasible approach for cancer treatment Curr. Cancer Drug Targets 2007, 7, 229-241 (Pubitemid 46699074)
30. Jackson, D. C.; Drummer, H. E.; Brown, L. E. Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus Virology 1994, 198, 613-623
31. Jackson, D. C.; Fitzmaurice, C. J.; Brown, L. E.; Zeng, W. Preparation and properties of totally synthetic immunogens Vaccine 1999, 18, 355-361 (Pubitemid 29444011)
32. Chua, B. Y.; Eriksson, E. M.; Poole, D. P.; Zeng, W.; Jackson, D. C. Dendritic cell acquisition of epitope cargo mediated by simple cationic peptide structures Peptides 2008, 29, 881-890
33. Kato, K.; Utani, A.; Suzuki, N.; Mochizuki, M.; Yamada, M.; Nishi, N.; Matsuura, H.; Shinkai, H.; Nomizu, M. Identification of neurite outgrowth promoting sites on the laminin alpha 3 chain G domain Biochemistry 2002, 41, 10747-10753 (Pubitemid 34971050)
34. Ghosh, S.; Jackson, D. C. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines Int. Immunol. 1999, 11, 1103-1110 (Pubitemid 29338752)
35. Shirota, H.; Sano, K.; Hirasawa, N.; Terui, T.; Ohuchi, K.; Hattori, T.; Shirato, K.; Tamura, G. Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells J. Immunol. 2001, 167, 66-74 (Pubitemid 32567762)
36. Heit, A.; Maurer, T.; Hochrein, H.; Bauer, S.; Huster, K. M.; Busch, D. H.; Wagner, H. Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells J. Immunol. 2003, 170, 2802-2805 (Pubitemid 36302148)
37. Prajeeth, C. K.; Jirmo, A. C.; Krishnaswamy, J. K.; Ebensen, T.; Guzman, C. A.; Weiss, S.; Constabel, H.; Schmidt, R. E.; Behrens, G. M. The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens Eur. J. Immunol. 2010, 40 (5) 1272-1283
38. Blander, J. M.; Medzhitov, R. Toll-dependent selection of microbial antigens for presentation by dendritic cells Nature 2006, 440, 808-812
39. Fehr, T.; Skrastina, D.; Pumpens, P.; Zinkernagel, R. M. T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 9477-9481 (Pubitemid 28506256)
40. Scaramuzzi, R. J.; Campbell, B. K.; Martin, G. B. Immunological approaches to fertility regulation in domestic livestock Immunol. Cell Biol. 1993, 71 (Part 5) 489-499 (Pubitemid 23316766)
41. Zeng, W.; Gauci, S.; Ghosh, S.; Walker, J.; Jackson, D. C. Characterisation of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH Vaccine 2005, 23, 4427-4435 (Pubitemid 40991228)
42. Zeng, W.; Ghosh, S.; Lau, Y. F.; Brown, L. E.; Jackson, D. C. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines J. Immunol. 2002, 169, 4905-4912 (Pubitemid 35217155)